| Molecular mechanisms of resistance to immunotherapy and antiangiogenic treatments in clear cell renal cell carcinoma PÁ Ballesteros, J Chamorro, MS Román-Gil, J Pozas, ... Cancers 13 (23), 5981, 2021 | 42 | 2021 |
| Receptor tyrosine kinase inhibitors for the treatment of recurrent and unresectable bone sarcomas V Albarrán, ML Villamayor, J Chamorro, DI Rosero, J Pozas, ... International Journal of Molecular Sciences 23 (22), 13784, 2022 | 20 | 2022 |
| Current landscape and potential challenges of immune checkpoint inhibitors in microsatellite stable metastatic colorectal carcinoma M San-Román-Gil, J Torres-Jiménez, J Pozas, J Esteban-Villarrubia, ... Cancers 15 (3), 863, 2023 | 13 | 2023 |
| Blood biomarkers of response to immune checkpoint inhibitors in non-small cell lung cancer YL Alfranca, MEO García, AG Rueda, PÁ Ballesteros, DR Rodríguez, ... Journal of Clinical Medicine 11 (11), 3245, 2022 | 9 | 2022 |
| Acute anti-Ma2 paraneoplastic encephalitis associated to pembrolizumab: a case report and review of literature V Albarrán, J Pozas, F Rodríguez, Á Carrasco, E Corral, Y Lage, ... Translational Lung Cancer Research 10 (7), 3303, 2021 | 6 | 2021 |
| Negative association of steroids with immunotherapy efficacy in a multi-tumor cohort: time and dose-dependent V Albarrán, P Guerrero, CG de Quevedo, C González, J Chamorro, ... Cancer Immunology, Immunotherapy 73 (10), 186, 2024 | 4 | 2024 |
| Clinical and genomic landscape of RAS mutations in gynecologic cancers J Son, Y Zhang, H Lin, O Mirallas, P Alvarez Ballesteros, M Nardo, ... Clinical Cancer Research, OF1-OF10, 2024 | 3 | 2024 |
| Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients P Guerrero, V Albarrán, C González-Merino, C García de Quevedo, ... The Oncologist, oyae284, 2024 | 1 | 2024 |
| 6P Clinical and molecular characteristics in non-small cell lung cancer patients with alteration in PIK3 pathway Y Lage, PÁ Ballesteros, MEO García, AG Rueda, EC de la Fuente, ... Journal of Thoracic Oncology 16 (4), S701, 2021 | 1 | 2021 |
| 56P Efficacy and safety of nivolumab (Nivo) in recurrent and/or metastatic platinum-refractory squamous cell carcinoma of head and neck (R/M SCCHN): A real-world data study JJS Castillo, JE Villarrubia, PA Ballesteros, PG Lopez, AS Rivas Annals of Oncology 31, S1438, 2020 | 1 | 2020 |
| Efficacy and safety of nivolumab (Nivo) in recurrent and/or metastatic platinum-refractory squamous cell carcinoma of head and neck (R/M SCCHN): A real-world data study JJ Soto Castillo, J Esteban Villarrubia, P Alvarez Ballesteros, ... ANNALS OF ONCOLOGY 31, S1438-S1438, 2020 | 1 | 2020 |
| 1849P Clinical predictors of long-term responses to immune checkpoint inhibitors (ICI) in a multi-tumor cohort VA Fernández, P Guerrero, CG Merino, CG de Quevedo Suero, ... Annals of Oncology 35, S1090, 2024 | | 2024 |
| 1063P Influence of infusion timing on the outcomes of immunotherapy in a multi-tumor cohort VA Fernández, DIR Rodriguez, J Chamorro-Perez, P Guerrero, ... Annals of Oncology 35, S705-S706, 2024 | | 2024 |
| Meta-analysis of perioperative immune checkpoint inhibitors in urothelial and renal cell carcinoma: Data from the latest available evidence. J Esteban Villarrubia, JT Torres Jiménez, M Ruiz Vico, ... Journal of Clinical Oncology 42 (16_suppl), e16617-e16617, 2024 | | 2024 |
| Total toxicity burden as a practical tool to quantify the overall severity of multiple adverse events in clinical trials. O Mirallas, R Lin, P Alvarez-Ballesteros, E Campbell, H Le, EE Dumbrava, ... Journal of Clinical Oncology 42 (16_suppl), 3156-3156, 2024 | | 2024 |
| Negative impact of steroids on the efficacy of immunotherapy in a multi-tumor cohort: time and dose-dependent V Albarrán, P Guerrero, CG de Quevedo, C González, J Chamorro, ... | | 2024 |
| 1066P Negative impact of steroids on the efficacy of immunotherapy in a multi-tumor cohort of patients: time and dose-dependent V Albarrán, P Guerrero, CG Merino, CG de Quevedo, AMB Corpa, ... Annals of Oncology 34, S643-S644, 2023 | | 2023 |
| 2180P Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients V Albarrán, JJ Serrano, P Sotoca-Rubio, AMB Corpa, VA Navarro, ... Annals of Oncology 34, S1129-S1130, 2023 | | 2023 |
| 533P Oligodendrogliomas: What is the impact after the introduction of the WHO molecular classification? MAV Salgado, J Earl, JMS Sanchez, Y Ruano, J Gutierrez, H Pian, LL Ley, ... Annals of Oncology 34, S403-S404, 2023 | | 2023 |
| Spinal Intramedullary Ewing Sarcoma with Meningeal Carcinomatosis: A Complete Response to Chemotherapy and Neuroaxis Irradiation. Case Report and Review of Literature V Albarrán, ML Villamayor, I Ruz, J Chamorro, DI Rosero, J Pozas, ... Journal of Cancer Science and Clinical Therapeutics 7, 75-81, 2023 | | 2023 |
